These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3946535)

  • 1. Effect of adding betaxolol to dipivefrin therapy.
    Weinreb RN; Ritch R; Kushner FH
    Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-masked comparison of betaxolol and dipivefrin for the treatment of increased intraocular pressure.
    Albracht DC; LeBlanc RP; Cruz AM; Lamping KA; Siegel LI; Stern KL; Kelley EP; Stoecker JF
    Am J Ophthalmol; 1993 Sep; 116(3):307-13. PubMed ID: 8357055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension.
    Rossetti L; Barbieri P; Velati P; Bujtar E; Orzalesi N
    Graefes Arch Clin Exp Ophthalmol; 1994 Nov; 232(11):670-4. PubMed ID: 7843592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of betaxolol and epinephrine in primary open angle glaucoma.
    Allen RC; Epstein DL
    Arch Ophthalmol; 1986 Aug; 104(8):1178-84. PubMed ID: 2874783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
    Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
    Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
    Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B
    Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.
    Widengård I; Mäepea O; Alm A
    Br J Ophthalmol; 1998 Apr; 82(4):404-6. PubMed ID: 9640189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased intraocular pressure in the hypertensive human eye with betaxolol, a beta 1-adrenergic antagonist.
    Feghali JG; Kaufman PL
    Am J Ophthalmol; 1985 Dec; 100(6):777-82. PubMed ID: 2866715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure].
    Ober M; Scharrer A
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):64-6. PubMed ID: 3959479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timolol and dipivalyl epinephrine combination therapy.
    McGuinness R; Frumar KD
    Aust J Ophthalmol; 1982 Aug; 10(3):179-82. PubMed ID: 7181758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
    Ober M; Scharrer A; Dausch D
    Klin Monbl Augenheilkd; 1987 Feb; 190(2):103-4. PubMed ID: 3573660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of 0.1% dipivalyl epinephrine and 1% epinephrine in patients with glaucoma or ocular hypertension].
    Shao H; Sun XY; Bai FG
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):104-7. PubMed ID: 8001439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betaxolol and acetazolamide. Combined ocular hypotensive effect.
    Smith JP; Weeks RH; Newland EF; Ward RL
    Arch Ophthalmol; 1984 Dec; 102(12):1794-5. PubMed ID: 6391442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of combined administration of 0.2% brimonidine and 0.5% betaxolol in treatment of primary open angle glaucoma and ocular hypertension.
    Chi W; Li A; Wang S; Zhu X
    Eye Sci; 2013 Dec; 28(4):190-4. PubMed ID: 24961091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
    Robin AL
    Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma.
    Allen RC; Hertzmark E; Walker AM; Epstein DL
    Am J Ophthalmol; 1986 May; 101(5):535-41. PubMed ID: 3518464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effect of betaxolol and epinephrine in primary open angle glaucoma.
    Bloom HR; Cech JM; Eston AB; Finegan JT; Gingold MP; Meyer L; Varr WF; Weinberg DA; Wilson C; Zalta AH
    Arch Ophthalmol; 1987 Oct; 105(10):1317-8. PubMed ID: 3662896
    [No Abstract]   [Full Text] [Related]  

  • 20. Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma.
    Berrospi AR; Leibowitz HM
    Arch Ophthalmol; 1982 Jun; 100(6):943-6. PubMed ID: 6124227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.